SpringWorks jumps as Merck KGaA reportedly in talks to acquire company
Merck KGaA (MKGAY), the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases drugmaker ...
Merck KGaA in talks to buy SpringWorks Therapeutics, Reuters reports
EST Merck KGaA (MKGAY) in talks to buy SpringWorks Therapeutics (SWTX), Reuters reportsMaximize Your Portfolio with Data Driven ...
Exclusive-Germany's Merck KGaA in Talks to Buy US Cancer Biotech Firm Springworks, Sources Say
Springworks, which listed its shares in New York in 2019, is a commercial-stage biotech firm that develops drugs to treat various forms of cancer and other rare diseases such as uterine cancer and ...
SpringWorks Therapeutics jumps on report of Merck KGaA takeover talks
SpringWorks Therapeutics ( NASDAQ: SWTX) soared 12% after a report that Merck KGaA ( OTCPK:MKGAF) is in advanced discussions to acquire the cancer and rare disease drugmaker.
pharmaphorum16h
Merck turns to cardiovascular pipeline for its post-Keytruda future
During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...